Citation Impact
Citing Papers
Improving Selection Criteria for Early Cystectomy in High-Grade T1 Bladder Cancer: A Meta-Analysis of 15,215 Patients
2015
Global Cancer Incidence and Mortality Rates and Trends—An Update
2015 Standout
CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion
2008 StandoutNobel
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Effects of distance learning on clinical management of LUTS in primary care: a randomised trial
2004
The study of the relation of DNA repair pathway genes SNPs and the sensitivity to radiotherapy and chemotherapy of NSCLC
2016
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
2011 Standout
The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis
2009 Standout
Cancer statistics, 2024
2024 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Body size and composition and prostate cancer risk: systematic review and meta-regression analysis
2006
Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease
2015
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Do Prognostic Parameters of Remission versus Relapse after Bacillus Calmette–Guérin (BCG) Immunotherapy Exist? Analysis of a Quarter Century of Literature
2003
Inflammation and cancer
2002 StandoutNature
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
A rare case of histopathological bladder necrosis associated with Actinobaculum schaalii: The incremental value of an accurate microbiological diagnosis using 16S rDNA sequencing
2014
Prognostic value of nuclear grade of renal cell carcinoma
1995
Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy
2006
Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study
2012
Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: From lab to clinic
2006
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
The prognostic impact of M‐CSF, CSF‐1 receptor, CD68 and CD3 in prostatic carcinoma
2008
VEGF targets the tumour cell
2013
Obesity and risk of cancer in Japan
2004
Benign prostatic hyperplasia: age-related tissue-remodeling
2005
Systematic Review of Complications of Prostate Biopsy
2013
European Guidelines on Upper Tract Urothelial Carcinomas: 2013 Update
2013
CATHETER-ASSOCIATED URINARY TRACT INFECTIONS
1997
The Epigenomics of Cancer
2007 Standout
Inhibition of angiogenesis and invasion in malignant gliomas
2007
Predictive factors of recurrence and survival of upper tract urothelial carcinomas
2011
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma
2014
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
2005 Standout
Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
2013
The natural history of incidentally detected small renal masses
2004
Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review
2016
Increased telomerase activity and comprehensive lifestyle changes: a pilot study
2008 StandoutNobel
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
Diagnosis of urothelial carcinoma from urine
2009
Bladder cancer
2016 Standout
Chronic immune activation and inflammation in the pathogenesis of aids and cancer
2002
Malignant Gliomas in Adults
2008 Standout
Bacillus Calmette‐Guérin therapy in stage Ta/T1 bladder cancer: prognostic factors for time to recurrence and progression
2004
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
2009 Standout
The role of American Society of Anesthesiologists scores in predicting urothelial carcinoma of the upper urinary tract outcome after radical nephroureterectomy: results from a national multi‐institutional collaborative study
2012
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
The Added Value of Percentage of Free to Total Prostate-specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men
2014
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
2008 Standout
Eicosanoids and cancer
2010 Standout
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Pathological and molecular mechanisms of prostate carcinogenesis: Implications for diagnosis, detection, prevention, and treatment
2003
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
2015 Standout
American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010
2010
High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder
2005
Mechanisms of BCG immunotherapy and its outlook for bladder cancer
2018
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
2017 Standout
Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus
2014
Serum PSA and Percent Free PSA Value Changes after Antibiotic Treatment
2008
Systemic bias in the medical literature on androgen deprivation therapy and its implication to clinical practice
2012
Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study
2012
Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung
2009
Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma
2013
Photodynamic Diagnosis (5-Aminolevulinic Acid) of Transitional Cell Carcinoma After Bacillus Calmette-Guérin Immunotherapy and Mitomycin C Intravesical Therapy
2009
International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume
2010
Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates
2019
Margin Status After Laparoscopic Radical Prostatectomy and the Index Lesion: Implications for Preoperative Evaluation of Tumor Focality in Prostate Cancer
2011
Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens
2005
A Prospective Comparative Study of Intravesical Bacillus Calmette-Guérin Therapy with the Tokyo or Connaught Strain for Nonmuscle Invasive Bladder Cancer
2013
Short term urinary catheter policies following urogenital surgery in adults
2006
Prognostic Significance of Tumor Volume in Radical Prostatectomy and Needle Biopsy Specimens
2011
Targeting of Tumor Cells for Human γδ T Cells by Nonpeptide Antigens
2001
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
THE ROLE OF INFLAMMATION IN THE PATHOGENESIS OF PROSTATE CANCER
2004
NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology
2011
Actinomyces and Related Organisms in Human Infections
2015 Standout
Postoperative nomogram to predict cancer‐specific survival after radical nephroureterectomy in patients with localised and/or locally advanced upper tract urothelial carcinoma without metastasis
2014
Engineering Camel Single-Domain Antibodies and Immobilization Chemistry for Human Prostate-Specific Antigen Sensing
2005
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Bladder Cancer
2020 Standout
The extracellular matrix at a glance
2010 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Printed educational materials: effects on professional practice and healthcare outcomes
2012 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Urinary PCA3 as a Predictor of Prostate Cancer in a Cohort of 3,073 Men Undergoing Initial Prostate Biopsy
2013
Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America
2010 Standout
CD4+CD25high T Cells Are Enriched in the Tumor and Peripheral Blood of Prostate Cancer Patients
2006
A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer (Review)
2014
Urinary Biomarkers for Diagnosis of Bladder Cancer
2015
Neutrophil Granulocytes Are Required for EffectiveBacillus Calmette-GuerinImmunotherapy of Bladder Cancer and Orchestrate Local Immune Responses
2006
Strategies for the removal of short-term indwelling urethral catheters in adults
2007
Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review
2021
Can urinary exosomes act as treatment response markers in prostate cancer?
2009
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Microbial Biofilms: from Ecology to Molecular Genetics
2000 Standout
Prosthetic Joint Infection
2014 Standout
Clinical Practice Recommendations for the Prevention and Management of Intravesical Therapy–Associated Adverse Events
2008
Global cancer statistics, 2012
2015 Standout
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
Industry sponsorship and research outcome
2017 Standout
Nanobodies: Natural Single-Domain Antibodies
2013 Standout
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
2002 StandoutNobel
Works of Jacques Irani being referenced
A review of guidelines on benign prostatic hyperplasia and lower urinary tract symptoms: are all guidelines the same?
2003
Recommandations en onco-urologie 2013 du CCAFU : Tumeurs de la vessie
2013
Influence of Positive Surgical Margin Status After Radical Nephroureterectomy on Upper Urinary Tract Urothelial Carcinoma Survival
2012
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer
2012
Prognostic Interest in Discriminating Muscularis Mucosa Invasion (T1a vs T1b) in Nonmuscle Invasive Bladder Carcinoma: French National Multicenter Study with Central Pathology Review
2012
Patient tolerance of transrectal ultrasound‐guided biopsy of the prostate
1997
High-grade inflammation in prostate cancer as a prognostic factor for biochemical recurrence after radical prostatectomy
1999
Risk stratification of metastatic recurrence in invasive upper urinary tract carcinoma after radical nephroureterectomy without lymphadenectomy
2013
Differential expression of the semaphorin 3A pathway in prostatic cancer
2009
One preoperative dose randomized against 3‐day antibiotic prophylaxis for transrectal ultrasonography‐guided prostate biopsy
2008
Leukocyturia as a predictor of tolerance and efficacy of intravesical BCG maintenance therapy for superficial bladder cancer
2001
Tolerability of bacille Calmette-Guérin maintenance therapy for superficial bladder cancer
2001
Urinary/serum prostate-specific antigen ratio: Comparison with free/total serum prostate-specific antigen ratio in improving prostate cancer detection
2005
Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma
2013
Sunitinib comparé à l’interféron-alpha dans le cancer du rein métastatique
2007
Influence of preoperative hydronephrosis on the outcome of urothelial carcinoma of the upper urinary tract after nephroureterectomy: the results from a multi-institutional French cohort
2012
Mutational Profile of Aggressive, Localised Prostate Cancer from African Caribbean Men Versus European Ancestry Men
2018
Obesity in relation to prostate cancer risk: comparison with a population having benign prostatic hyperplasia
2003
Infective Endocarditis after Transrectal Prostatic Biopsy
2002
Diagnostic et prise en charge des événements indésirables survenant au décours des instillations endovésicales de BCG pour le traitement des tumeurs de vessie n’infiltrant pas le muscle (TVNIM) : revue du comité de cancérologie de l’Association française d’urologie
2012
External Validation of Urinary PCA3-Based Nomograms to Individually Predict Prostate Biopsy Outcome
2010
Oncological risk of laparoscopic surgery in urothelial carcinomas
2008
Prognostic Significance of Tumor Volume after Radical Prostatectomy: A Multivariate Analysis of Pathological Prognostic Factors
2002
BTA <i>stat</i> and BTA TRAK: A Comparative Evaluation of Urine Testing for the Diagnosis of Transitional Cell Carcinoma of the Bladder
1999
Renal Tumor Size: Comparison between Computed Tomography and Surgical Measurements
2001
Effect of Nonsteroidal Anti-Inflammatory Agents and Finasteride on Prostate Cancer Risk
2002
Clinical Evaluation of the PCA3 Assay in Guiding Initial Biopsy Decisions
2011
Systematic Removal of Catheter 48 Hours Following Transurethral Resection and 24 Hours Following Transurethral Incision of Prostate: A Prospective Randomized Analysis of 213 Patients
1995
Tumeurs urothéliales
2007
Impact de la pandémie de COVID-19 sur l’activité chirurgicale au sein des services d’urologie de l’Assistance Publique – Hôpitaux de Paris
2020
[Urinary leukocytes as a new prognostic marker of therapeutic response and of adverse effects associated with the maintenance treatment with endovesical BCG, for the prophylaxis of superficial bladder tumors].
2001
Androgen-Deprivation Therapy in Prostate Cancer: A European Expert Panel Review
2010
Prognostic Value of Histological Grade and Nuclear Grade in Renal Adenocarcinoma
1994
[Epidemiology of bladder cancer].
2003
[AFU recommendations 1998. "Committee on Cancer of the French Association of Urology"].
2002
Inflammation in Benign Prostatic Hyperplasia: Correlation With Prostate Specific Antigen Value
1997